Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.
2.

Triazolam biotransformation by human liver microsomes in vitro: effects of metabolic inhibitors and clinical confirmation of a predicted interaction with ketoconazole.

von Moltke LL, Greenblatt DJ, Harmatz JS, Duan SX, Harrel LM, Cotreau-Bibbo MM, Pritchard GA, Wright CE, Shader RI.

J Pharmacol Exp Ther. 1996 Feb;276(2):370-9.

PMID:
8632299
3.

Bladder mast cell expression of high affinity oestrogen receptors in patients with interstitial cystitis.

Pang X, Cotreau-Bibbo MM, Sant GR, Theoharides TC.

Br J Urol. 1995 Feb;75(2):154-61.

PMID:
7850318
4.

Inhibitors of alprazolam metabolism in vitro: effect of serotonin-reuptake-inhibitor antidepressants, ketoconazole and quinidine.

von Moltke LL, Greenblatt DJ, Cotreau-Bibbo MM, Harmatz JS, Shader RI.

Br J Clin Pharmacol. 1994 Jul;38(1):23-31.

5.

Inhibition of desipramine hydroxylation in vitro by serotonin-reuptake-inhibitor antidepressants, and by quinidine and ketoconazole: a model system to predict drug interactions in vivo.

von Moltke LL, Greenblatt DJ, Cotreau-Bibbo MM, Duan SX, Harmatz JS, Shader RI.

J Pharmacol Exp Ther. 1994 Mar;268(3):1278-83.

PMID:
8138941
6.

Caffeine treatment and withdrawal in mice: relationships between dosage, concentrations, locomotor activity and A1 adenosine receptor binding.

Kaplan GB, Greenblatt DJ, Kent MA, Cotreau-Bibbo MM.

J Pharmacol Exp Ther. 1993 Sep;266(3):1563-72.

PMID:
8371158

Supplemental Content

Loading ...
Support Center